Your institution may have access to this item. Find your institution then sign in to continue.
Title
Economic analyses of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review.
Authors
Kamal-Bahl, Sachin; Doshi, Jalpa; Campbell, James
Abstract
To systematically review all published economic analyses of the only 2 available agents for respiratory syncytial virus immunoprophylaxis in high-risk infants: respiratory syncytial virus immunoglobulin intravenous and palivizumab.